Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: Host factors as major determinants of C trachomatis mediated pathogenies

Journal of Clinical Pathology

Volumn 57, Issue 6, 2004, Pages 657-659

  Lyons, J M ^a   Ito Jr , J I ^a   Morre S A ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; EXPERIMENTAL MODEL; FEMALE; GENITAL TRACT INFECTION; HOST; HUMAN; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEROTYPE; STRAIN DIFFERENCE;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MALE; MICE;

EID: 2642558748     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.013086     Document Type: Article

References (10)

1. Geisler WM, Suchland RJ, Whittington WLH, et al. The relationship of serovars to clinical manifestations of urogenital Chlamydia trachomatis infection. Sexual Transm Dis 2003;30:160-5.
2. Ito JI, Lyons JM, Airo-Brown LP. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect Immun 1990;58:2021-3.
3. Lan J, van den Hoek A, Ossewaarde JM, et al. Genotyping of Chlamydia trachomatis serovars derived from heterosexual partners and a detailed genomic analysis of serovar F. Genitourin Med 1995;71:299-303.
4. Tuffrey M, Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Micribiol Lett 1988;12:111-15.
5. Ito JI, Harrison HR, Alexander ER, et al. Establishment of genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis. J Infect Dis 1984;150:577-82.
6. Morré SA, Sillekens P, Jacobs MV, et al. RNA amplification by NASBA with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples. J Clin Microbiol 1996;34:3108-14.
7. Caldwell HD, Wood H, et al. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest 2003;111:1757-69.
8. Cohen CR, Sinei SS, Bukusi EA, et al. Human leukocyte antigen class II DQ alleles associated with Chlamydia trachomatis tubal infertility. Obstet Gynecol 2000;95:72-7.
9. Kinnunen AH, Surcel HM, Lehtinen M, et al. HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum Reprod 2002;17:2073-8.
10. Morré SA, Murillo LS, Bruggeman CA, et al. The role that the functional Asp299Gly polymorphism in the Toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis associated tubal infertility. J Infect Dis 2003;187:341-3.